Crescent Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 05-12-2024
- Paid Up Capital ₹ 2.50 M
as on 05-12-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.30 Cr
as on 05-12-2024
- Revenue 4.63%
(FY 2023)
- Profit 3.67%
(FY 2023)
- Ebitda 3.96%
(FY 2023)
- Net Worth 11.80%
(FY 2023)
- Total Assets 3.40%
(FY 2023)
About Crescent Life Sciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹4.30 Cr.
Amarkant Upadhyaya, Vijay Sharma, Anila Nigam, and Four other members serve as directors at the Company.
- CIN/LLPIN
U51101UP2012PTC048939
- Company No.
048939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Feb 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Crescent Life Sciences Private Limited offer?
Crescent Life Sciences Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Dog Food, Printing Inks & Other Supplies, Printing Ink, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Common Disease Medicines, Cough Syrup.
Who are the key members and board of directors at Crescent Life Sciences?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Nigam  | Director | 16-Feb-2012 | Current |
| Amarkant Upadhyaya | Director | 16-Feb-2012 | Current |
| Vijay Sharma | Director | 16-Feb-2012 | Current |
| Anila Nigam | Director | 16-Feb-2012 | Current |
| Vishal Mishra | Director | 16-Feb-2012 | Current |
| Ekta Upadhyaya | Director | 16-Feb-2012 | Current |
Financial Performance of Crescent Life Sciences.
Crescent Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.63% increase. The company also saw a slight improvement in profitability, with a 3.67% increase in profit. The company's net worth Soared by an impressive increase of 11.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crescent Life Sciences?
Unlock access to Crescent Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Varda Dios Health Care Private LimitedActive 6 years 8 monthsAmarkant Upadhyaya, Vijay Sharma and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Oct 2020 | ₹1.70 M | Open |
Bank Of India Creation Date: 19 Jun 2020 | ₹2.50 M | Open |
Bank Of India Creation Date: 05 Dec 2018 | ₹1.40 Cr | Open |
How Many Employees Work at Crescent Life Sciences?
Crescent Life Sciences has a workforce of 59 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crescent Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crescent Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
